Anthera Pharmaceuticals Inc (ANTH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0001 unch (unch) 04/28/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0001 unch (unch) 11:02 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ANTH | SCNI | GRI | ||
| Company | Anthera Pharmaceuticals Inc | Scinai Immunotherapeutics Ltd ADR | Gri Bio Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.0001 | 2.59 | 1.8200 | ||
| High | 0.0001 | 2.59 | 1.9300 | ||
| Low | 0.0001 | 2.40 | 1.6900 | ||
| Last | 0.0001 | 2.44 | 1.7800 | ||
| Change | unch | -0.07 | -0.0400 | ||
| % Change | unch | -2.92% | -2.20% | ||
| Volume | 4,500 | 5,500 | 169,200 | ||
| 20-Day Average Volume | N/A | 18,025 | 1,057,910 | ||
| Previous Close | 0.0001 | 2.51 | 1.8200 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 2.35 | 1.6245 | ||
| 20-Day Raw Stochastic | N/A | 49.55% | 6.79% | ||
| 20-Day Relative Strength | N/A | 43.55% | 32.40% | ||
| Weighted Alpha | N/A | -54.17 | -88.37 | ||
| Today's Opinion | N/A | 88% Sell | 88% Sell | ||
| Previous Opinion | N/A | 88% Sell | 88% Sell | ||
| Last Month's Opinion | N/A | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 04/14/25 | +19.03% since 04/21/25 | +21.92% since 04/21/25 | ||
| Low | 0.0001 on 04/28/25 | 2.08 on 04/22/25 | 1.4200 on 04/22/25 | ||
| High | 0.0001 on 04/28/25 | 2.69 on 04/25/25 | 2.1100 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | unch since 03/11/25 | -12.85% since 03/28/25 | -59.23% since 03/28/25 | ||
| Low | 0.0001 on 04/28/25 | 1.90 on 04/15/25 | 1.1000 on 04/09/25 | ||
| High | 0.0001 on 04/28/25 | 2.99 on 04/04/25 | 11.1200 on 04/01/25 | ||
| 3-Month | |||||
| %Chg | unch since 12/30/24 | -31.26% since 01/28/25 | -83.38% since 01/28/25 | ||
| Low | 0.0001 on 04/28/25 | 1.90 on 04/15/25 | 1.1000 on 04/09/25 | ||
| High | 0.0001 on 04/28/25 | 3.99 on 02/07/25 | 11.9000 on 01/30/25 | ||
| 6-Month | |||||
| %Chg | -50.00% since 10/28/24 | -29.68% since 10/28/24 | -84.52% since 10/28/24 | ||
| Low | 0.0001 on 04/28/25 | 1.90 on 04/15/25 | 1.1000 on 04/09/25 | ||
| High | 0.0002 on 12/26/24 | 3.99 on 02/07/25 | 22.9500 on 11/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 0 | 2,278 | 935 | ||
| Shares Outstanding, K | 0 | 934 | 525 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -26,870,000 | -6,500,000 | -8,210,000 | ||
| Last Quarter Sales | N/A | 170,000 | 0 | ||
| Last Quarter Net Income | N/A | 10,460,000 | -1,950,000 | ||
| 60-Month Beta | 1.47 | 2.68 | -1.72 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 8.40 on 11/22/24 | -11.39 on 11/14/24 | ||
| Latest Earnings Date | 07/02/19 | 05/21/25 | 05/09/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 12/19/19 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||